Have Scientists found a cure to cancer ??
Advertisement
Heads seemed to turn, when a medical scientist, Dr. Stanley Riddell at Fred Hutchinson Cancer Research Centre shared the preliminary results of an ongoing trial on new adoptive T-cell therapy strategies for cancer during an annual conference. The preliminary results showed that 27 out of 29 patients with an advanced blood cancer who received an experimental, "living" immunotherapy as part of a clinical trial experienced sustained remissions.
While the scientist himself cautioned, that the results are preliminary and much more study needs to be done, the medical world seems to be now looking forward to the study whose " early data is unprecedented."
Riddle and his colleagues are working on a trial designed to test the safety of the latest iteration of an experimental immunotherapy in which a patient's own T cells are reprogrammed to eliminate his or her cancer. The reprogramming involves genetically engineering the T cells with synthetic molecules called chimeric antigen receptors, or CARs, that enable them to target and destroy tumor cells bearing a particular target. Trial participants included patients with acute lymphoblastic leukemia, non-Hodgkin lymphoma and chronic lymphocytic leukemia.
While the scientist himself cautioned, that the results are preliminary and much more study needs to be done, the medical world seems to be now looking forward to the study whose " early data is unprecedented."
Riddle and his colleagues are working on a trial designed to test the safety of the latest iteration of an experimental immunotherapy in which a patient's own T cells are reprogrammed to eliminate his or her cancer. The reprogramming involves genetically engineering the T cells with synthetic molecules called chimeric antigen receptors, or CARs, that enable them to target and destroy tumor cells bearing a particular target. Trial participants included patients with acute lymphoblastic leukemia, non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.